In the P304 Phase III study, Moderna’s mRNA-1010 demonstrated a 26.6% relative efficacy over a standard-dose flu vaccine in adults aged 50+, showing consistent protection across strains and age groups ...

For decades, the dream of fixing harmful mutations in mitochondrial DNA felt out of reach. Scientists have long known these ...

CRISPR Therapeutics is revolutionizing medicine with gene editing. Learn more about CRSP's breakthroughs, stock rally, and ...

Technology can be harnessed to design novel and enhanced molecules that address challenges in biotechnology or medicine.

“So, Donald Trump normally leans into stories in which there’s controversy,” Enten said. “This is a story he is trying to get ...

Welcome to our live blog tracking the latest news and developments from the United States. Stay updated with real-time ...

Prince Harry and Meghan Markle pledged in 2019 to have no more than two children for the sake of the earth, and some groups ...

The authors proposed two hypotheses: first, that methamphetamine induces neuroinflammation, and second, that it alters neuronal stem cell differentiation. These are valuable hypotheses, and the ...

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

The public policy practice at Baker Donelson is joining forces with the Daschle Group to form DB3, which stands for ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...